Gennex Laboratories (BOM:531739) E10: ₹0.45 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531739 Gennex Laboratories Ltd BOM:531739
79 GF Score
Price ₹12.15
GF Value ₹16.93
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Gennex Laboratories E10?

Gennex Laboratories BOM:531739 +0.91% 79 E10 is ₹0.45 as of Jun. 2026. GuruFocus rates BOM:531739 with a GF Score™ of 79/100 and a GF Value™ of ₹16.93 (Modestly Undervalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Gennex Laboratories's adjusted earnings per share data for the three months ended in Jun. 2026 was ₹0.192. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹0.45 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Gennex Laboratories's average E10 Growth Rate was 18.40% per year. During the past 3 years, the average E10 Growth Rate was 27.00% per year. During the past 5 years, the average E10 Growth Rate was 26.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Gennex Laboratories was 28.40% per year. The lowest was 27.00% per year. And the median was 27.50% per year.

As of today (2026-08-26), Gennex Laboratories's current stock price is ₹12.15. Gennex Laboratories's E10 for the quarter that ended in Jun. 2026 was ₹0.45. Gennex Laboratories's Shiller PE Ratio of today is 27.00.

During the past 13 years, the highest Shiller PE Ratio of Gennex Laboratories was 81.16. The lowest was 19.54. And the median was 39.23.


Gennex Laboratories  (BOM:531739) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Gennex Laboratories's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=12.15/0.45
=27.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Gennex Laboratories was 81.16. The lowest was 19.54. And the median was 39.23.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Gennex Laboratories E10 Related Terms


Gennex Laboratories E10 Historical Data

* Premium members only.

The historical data trend for Gennex Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gennex Laboratories E10 Chart

Gennex Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.21 0.29 0.36 0.43

Gennex Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.40 0.41 0.43 0.45

BOM:531739 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Gennex Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gennex Laboratories Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gennex Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Gennex Laboratories's Shiller PE Ratio falls into.


BOM:531739
79GF Score
Gennex Laboratories Ltd BOM:531739
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gennex Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Gennex Laboratories's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.192/167.3573*167.3573
=0.192

Current CPI (Jun. 2026) = 167.3573.

Gennex Laboratories Quarterly Data

per share eps CPI Adj_EPS
201609 0.102 105.961 0.161
201612 0.074 105.196 0.118
201703 -0.017 105.196 -0.027
201706 0.029 107.109 0.045
201709 0.030 109.021 0.046
201712 0.023 109.404 0.035
201803 -0.017 109.786 -0.026
201806 0.035 111.317 0.053
201809 0.036 115.142 0.052
201812 0.062 115.142 0.090
201903 0.034 118.202 0.048
201906 0.060 120.880 0.083
201909 0.042 123.175 0.057
201912 0.015 126.235 0.020
202003 0.023 124.705 0.031
202006 0.028 127.000 0.037
202009 0.067 130.118 0.086
202012 0.093 130.889 0.119
202103 0.119 131.771 0.151
202106 0.072 134.084 0.090
202109 0.087 135.847 0.107
202112 0.062 138.161 0.075
202203 0.081 138.822 0.098
202206 0.060 142.347 0.071
202209 0.083 144.661 0.096
202212 0.067 145.763 0.077
202303 0.140 146.865 0.160
202306 0.161 150.280 0.179
202309 0.160 151.492 0.177
202312 0.156 152.924 0.171
202403 0.177 153.035 0.194
202406 0.205 155.789 0.220
202409 0.212 157.882 0.225
202412 0.220 158.323 0.233
202503 0.135 157.552 0.143
202506 0.206 159.755 0.216
202509 0.207 162.289 0.213
202512 0.216 163.281 0.221
202603 0.156 164.272 0.159
202606 0.192 167.357 0.192

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹0.45 mean?
Gennex Laboratories (BOM:531739) has a E10 of ₹0.45 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Gennex Laboratories and its competitors.
Is Gennex Laboratories' E10 too high?
Gennex Laboratories' current E10 is ₹0.45. Overall, Gennex Laboratories has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Gennex Laboratories' E10 compare to ZTS?
Gennex Laboratories' E10 of ₹0.45 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Gennex Laboratories and its competitors. Gennex Laboratories's current E10 is ₹0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gennex Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Gennex Laboratories (BOM:531739) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹16.93, compared to a current price of ₹12.15 — trading 28.2% below its estimated fair value. The current E10 is ₹0.45. Gennex Laboratories' overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Gennex Laboratories (BOM:531739), the current E10 is ₹0.45 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gennex Laboratories (BOM:531739) Overvalued in 2026?

Based on GuruFocus' analysis, Gennex Laboratories stock appears to be undervalued. The current stock price of ₹12.15 is trading 28.2% below its estimated GF Value™ of ₹16.93. GuruFocus considers Gennex Laboratories to be Modestly Undervalued.

Key valuation signals for BOM:531739:

  • E10: ₹0.45
  • GF Value™: ₹16.93 vs. price of ₹12.15 (28.2% below fair value)
  • GF Score™: 79/100 with 8 warning signs

No single metric tells the full story. See the BOM:531739 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gennex Laboratories Business Description

Address Akash Ganga, Plot No. 144, 4th Floor, Srinagar Colony, Hyderabad, TG, IND, 500 073
Gennex Laboratories Ltd is engaged in the manufacturing of bulk drugs, and intermediates, Biotech Products. Geographically, the group has a business presence in Bangladesh, Egypt, Germany, Guatemala, Iran, Israel and other countries. Its products include Guaifenesin, Methocarbamol, Fluconazole and Phenazopyridine, among others.
79GF Score

Get the complete analysis for BOM:531739

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹12.15
Price
₹16.93
GF Value